Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


30.07.2018

4 AIDS
4 AIDS Res Hum Retroviruses
2 BMC Pediatr
1 BMJ
1 Br J Haematol
5 J Acquir Immune Defic Syndr
1 J Immunol
1 J Infect Dis
1 J Virol
2 JAMA
9 Lancet
1 Lancet Gastroenterol Hepatol
2 Lancet Glob Health
7 Lancet HIV
1 Nat Rev Immunol
1 Pediatrics
16 PLoS One
1 PLoS Pathog
2 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. PAPASAVVAS E, Lada SM, Joseph J, Yin X, et al
    Analytical antiretroviral therapy interruption does not irreversibly change preinterruption levels of cellular HIV.
    AIDS. 2018;32:1763-1772.
    PubMed     Text format     Abstract available


  2. Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients: Erratum.
    AIDS. 2018;32:1909-1910.
    PubMed     Text format    


  3. Effect of cytomegalovirus and Epstein-Barr virus replication on intestinal mucosal gene expression and microbiome composition of HIV-infected and uninfected individuals: Erratum.
    AIDS. 2018;32:1911.
    PubMed     Text format    

  4. BRUMME ZL, Kinloch NN, Sanche S, Wong A, et al
    Extensive host immune adaptation in a concentrated North American HIV epidemic.
    AIDS. 2018 Jul 25. doi: 10.1097/QAD.0000000000001912.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  5. DENNIS AM, Volz E, Frost S, Hossain ASMM, et al
    HIV-1 transmission clustering and phylodynamics highlight the important role of young men who have sex with men.
    AIDS Res Hum Retroviruses. 2018 Jul 20. doi: 10.1089/AID.2018.0039.
    PubMed     Text format     Abstract available

  6. VALLECILLO G, Robles MJ, Fonseca F, Tamarit C, et al
    Integrated care on leaving hospital against medical advice among HIV-infected people with substance use disorders.
    AIDS Res Hum Retroviruses. 2018 Jul 26. doi: 10.1089/AID.2018.0087.
    PubMed     Text format     Abstract available

  7. MORRISON C, Fichorova R, Chen PL, Kwok C, et al
    A Longitudinal Assessment of Cervical Inflammation and Immunity associated with HIV-1 Infection, Hormonal Contraception and Pregnancy.
    AIDS Res Hum Retroviruses. 2018 Jul 26. doi: 10.1089/AID.2018.0022.
    PubMed     Text format     Abstract available

  8. IBRAHIM M, Brooks K, Castillo-Mancilla J, McHugh C, et al
    Bioequivalence of Tenofovir and Emtricitabine following Co-Encapsulation with the Proteus(R) Ingestible Sensor.
    AIDS Res Hum Retroviruses. 2018 Jul 26. doi: 10.1089/AID.2018.0081.
    PubMed     Text format     Abstract available


    BMC Pediatr

  9. PILGRIM NA, Okal J, Matheka J, Mukui I, et al
    Challenges to and opportunities for the adoption and routine use of early warning indicators to monitor pediatric HIV drug resistance in Kenya.
    BMC Pediatr. 2018;18:243.
    PubMed     Text format     Abstract available

  10. FAMOROTI T, Sibanda W, Ndung'u T
    Prevalence and seasonality of common viral respiratory pathogens, including Cytomegalovirus in children, between 0-5 years of age in KwaZulu-Natal, an HIV endemic province in South Africa.
    BMC Pediatr. 2018;18:240.
    PubMed     Text format     Abstract available


    BMJ

  11. HURLEY R
    HIV/AIDS: complacency risks reversing progress on ending epidemic, conference hears.
    BMJ. 2018;362:k3241.
    PubMed     Text format    


    Br J Haematol

  12. BIGENWALD C, Fardet L, Coppo P, Meignin V, et al
    A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis.
    Br J Haematol. 2018 Jul 24. doi: 10.1111/bjh.15506.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  13. GOEDEL WC, King MRF, Lurie MN, Nunn AS, et al
    Effect of Racial Inequities in Pre-Exposure Prophylaxis Use on Racial Disparities in HIV Incidence Among Men Who Have Sex with Men: A Modeling Study.
    J Acquir Immune Defic Syndr. 2018 Jul 20. doi: 10.1097/QAI.0000000000001817.
    PubMed     Text format     Abstract available

  14. JESPERSEN S, Honge BL, Krarup H, Medstrand P, et al
    Protease Inhibitors or NNRTIs as First-Line HIV-1 Treatment in West Africa (PIONA): a Randomised Controlled Trial.
    J Acquir Immune Defic Syndr. 2018 Jul 20. doi: 10.1097/QAI.0000000000001820.
    PubMed     Text format     Abstract available

  15. MACKESY-AMITI ME, Boodram B, Handanagic S, Paz-Bailey G, et al
    Latent Classes of Sexual Risk Behavior and Engagement in Outreach, Intervention and Prevention Services Among Women who Inject Drugs Across 20 u.s. Cities.
    J Acquir Immune Defic Syndr. 2018 Jul 20. doi: 10.1097/QAI.0000000000001816.
    PubMed     Text format     Abstract available

  16. DELANEY JA, Nance RM, Whitney BM, Altice FL, et al
    Reduced use of illicit substances, even without abstinence, is associated with improved depressive symptoms among people living with HIV.
    J Acquir Immune Defic Syndr. 2018 Jul 19. doi: 10.1097/QAI.0000000000001803.
    PubMed     Text format     Abstract available

  17. NAPIERALA S, Chabata ST, Fearon E, Davey C, et al
    Engagement in HIV Care Among young female sex workers in Zimbabwe.
    J Acquir Immune Defic Syndr. 2018 Jul 19. doi: 10.1097/QAI.0000000000001815.
    PubMed     Text format     Abstract available


    J Immunol

  18. KUMAR NA, van der Sluis RM, Mota T, Pascoe R, et al
    Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4(+) T Cells.
    J Immunol. 2018 Jul 20. pii: jimmunol.1701233. doi: 10.4049/jimmunol.1701233.
    PubMed     Text format     Abstract available


    J Infect Dis

  19. SIEDNER MJ, Triant V
    Undetectable = Untransmittable and Your Health: The personal benefits of early and continuous therapy for HIV infection.
    J Infect Dis. 2018 Jul 19. pii: 5055762. doi: 10.1093.
    PubMed     Text format    


    J Virol

  20. PENNINGTON MR, Voorhees IEH, Callaway HM, Dehghanpir SD, et al
    The HIV integrase inhibitor raltegravir inhibits felid alphaherpesvirus 1 (FeHV-1) replication by targeting both DNA replication and late gene expression.
    J Virol. 2018 Jul 25. pii: JVI.00994-18. doi: 10.1128/JVI.00994.
    PubMed     Text format     Abstract available


    JAMA

  21. RIDDELL J 4TH
    2018 IAS-USA Recommendations for the Use of Antiretroviral Therapy for HIV: Building on Decades of Progress.
    JAMA. 2018;320:347-349.
    PubMed     Text format    

  22. SAAG MS, Benson CA, Gandhi RT, Hoy JF, et al
    Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society-USA Panel.
    JAMA. 2018;320:379-396.
    PubMed     Text format     Abstract available


    Lancet

  23. SHANNON K, Crago AL, Baral SD, Bekker LG, et al
    The global response and unmet actions for HIV and sex workers.
    Lancet. 2018 Jul 20. pii: S0140-6736(18)31439.
    PubMed     Text format     Abstract available

  24. BAROUCH DH, Tomaka FL, Wegmann F, Stieh DJ, et al
    Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
    Lancet. 2018;392:232-243.
    PubMed     Text format     Abstract available

  25. GUPTA-WRIGHT A, Corbett EL, van Oosterhout JJ, Wilson D, et al
    Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31267.
    PubMed     Text format     Abstract available

  26. SANDS P
    HIV: from exceptionalism to endgame.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31434.
    PubMed     Text format    

  27. MAKOFANE K, Spire B, Mtetwa P
    Tackling global health inequities in the HIV response.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31441.
    PubMed     Text format    

  28. NATHAVITHARANA RR, Pai M
    New strategies for inpatients with HIV and tuberculosis.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31442.
    PubMed     Text format    

  29. DAS P, Horton R
    Beyond the silos: integrating HIV and global health.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31466.
    PubMed     Text format    

  30. BEKKER LG, Alleyne G, Baral S, Cepeda J, et al
    Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission.
    Lancet. 2018 Jul 19. pii: S0140-6736(18)31070.
    PubMed     Text format    

  31. PAVLAKIS GN, Felber BK
    A new step towards an HIV/AIDS vaccine.
    Lancet. 2018;392:192-194.
    PubMed     Text format    


    Lancet Gastroenterol Hepatol

  32. SHIHA G, Metwally AM, Soliman R, Elbasiony M, et al
    An educate, test, and treat programme towards elimination of hepatitis C infection in Egypt: a community-based demonstration project.
    Lancet Gastroenterol Hepatol. 2018 Jul 17. pii: S2468-1253(18)30139.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  33. ANAM F, Chung C, Dilmitis S, Kenkem C, et al
    Time to realise our sexual and reproductive health and rights.
    Lancet Glob Health. 2018 Jul 18. pii: S2214-109X(18)30352.
    PubMed     Text format    

  34. NARASIMHAN M, Pillay Y, Garcia PJ, Allotey P, et al
    Investing in sexual and reproductive health and rights of women and girls to reach HIV and UHC goals.
    Lancet Glob Health. 2018 Jul 18. pii: S2214-109X(18)30316.
    PubMed     Text format    


    Lancet HIV

  35. ORTBLAD KF, Oldenburg CE
    Tailoring combination HIV prevention for female sex workers.
    Lancet HIV. 2018 Jul 17. pii: S2352-3018(18)30136.
    PubMed     Text format    

  36. CEPEDA JA, Eritsyan K, Vickerman P, Lyubimova A, et al
    Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study.
    Lancet HIV. 2018 Jul 19. pii: S2352-3018(18)30168.
    PubMed     Text format     Abstract available

  37. COWAN FM, Davey C, Fearon E, Mushati P, et al
    Targeted combination prevention to support female sex workers in Zimbabwe accessing and adhering to antiretrovirals for treatment and prevention of HIV (SAPPH-IRe): a cluster-randomised trial.
    Lancet HIV. 2018 Jul 17. pii: S2352-3018(18)30111.
    PubMed     Text format     Abstract available

  38. HARDING R
    Palliative care as an essential component of the HIV care continuum.
    Lancet HIV. 2018 Jul 16. pii: S2352-3018(18)30110.
    PubMed     Text format     Abstract available

  39. BAVINTON BR, Pinto AN, Phanuphak N, Grinsztejn B, et al
    Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.
    Lancet HIV. 2018 Jul 16. pii: S2352-3018(18)30132.
    PubMed     Text format     Abstract available

  40. COHEN MS
    Treatment for HIV prevention, one couple at a time.
    Lancet HIV. 2018 Jul 16. pii: S2352-3018(18)30138.
    PubMed     Text format    

  41. ZELENEV A
    Access to opioid agonist therapy in Russia: time for reform.
    Lancet HIV. 2018 Jul 19. pii: S2352-3018(18)30170.
    PubMed     Text format    


    Nat Rev Immunol

  42. MALDINI CR, Ellis GI, Riley JL
    CAR T cells for infection, autoimmunity and allotransplantation.
    Nat Rev Immunol. 2018 Jul 25. pii: 10.1038/s41577-018-0042.
    PubMed     Text format     Abstract available


    Pediatrics

  43. JICHLINSKI A, Badolato G, Pastor W, Goyal MK, et al
    HIV and Syphilis Screening Among Adolescents Diagnosed With Pelvic Inflammatory Disease.
    Pediatrics. 2018 Jul 24. pii: peds.2017-4061. doi: 10.1542/peds.2017-4061.
    PubMed     Text format     Abstract available


    PLoS One

  44. EVANS H, Balasegaram S, Douthwaite S, Hunter L, et al
    An innovative approach to increase viral hepatitis diagnoses and linkage to care using opt-out testing and an integrated care pathway in a London Emergency Department.
    PLoS One. 2018;13:e0198520.
    PubMed     Text format     Abstract available

  45. SHELL-DUNCAN B, Moreau A, Wander K, Smith S, et al
    The role of older women in contesting norms associated with female genital mutilation/cutting in Senegambia: A factorial focus group analysis.
    PLoS One. 2018;13:e0199217.
    PubMed     Text format     Abstract available

  46. TSO FY, Kang G, Kwon EH, Julius P, et al
    Brain is a potential sanctuary for subtype C HIV-1 irrespective of ART treatment outcome.
    PLoS One. 2018;13:e0201325.
    PubMed     Text format     Abstract available

  47. HOFFMANN CJ, Milovanovic M, Kinghorn A, Kim HY, et al
    Value stream mapping to characterize value and waste associated with accessing HIV care in South Africa.
    PLoS One. 2018;13:e0201032.
    PubMed     Text format     Abstract available

  48. KNIGHT R, Krusi A, Carson A, Fast D, et al
    Criminalization of HIV non-disclosure: Narratives from young men living in Vancouver, Canada.
    PLoS One. 2018;13:e0201110.
    PubMed     Text format     Abstract available

  49. GARCIA PJ, Hernandez-Cordova G, Pourjavaheri P, Gomez-Paredes HJ, et al
    Knowledge, attitudes and practices related to tuberculosis in pharmacy workers in a cross-sectional survey in El Agustino, Peru.
    PLoS One. 2018;13:e0196648.
    PubMed     Text format     Abstract available

  50. CRUCITTI T, Hardy L, van de Wijgert J, Agaba S, et al
    Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women.
    PLoS One. 2018;13:e0201003.
    PubMed     Text format     Abstract available

  51. PRAKASH K, Gianella S, Dube K, Taylor J, et al
    Willingness to participate in HIV research at the end of life (EOL).
    PLoS One. 2018;13:e0199670.
    PubMed     Text format     Abstract available

  52. YOUNG N, Taegtmeyer M, Aol G, Bigogo GM, et al
    Integrated point-of-care testing (POCT) of HIV, syphilis, malaria and anaemia in antenatal clinics in western Kenya: A longitudinal implementation study.
    PLoS One. 2018;13:e0198784.
    PubMed     Text format     Abstract available

  53. DALE R, Guo B
    Estimating epidemiological parameters of a stochastic differential model of HIV dynamics using hierarchical Bayesian statistics.
    PLoS One. 2018;13:e0200126.
    PubMed     Text format     Abstract available

  54. WEISS G, Smith DK, Newman S, Wiener J, et al
    PrEP implementation by local health departments in US cities and counties: Findings from a 2015 assessment of local health departments.
    PLoS One. 2018;13:e0200338.
    PubMed     Text format     Abstract available

  55. HINO S, Grodensky C, Rutstein SE, Golin C, et al
    HIV status disclosure during acute HIV infection in Malawi.
    PLoS One. 2018;13:e0201265.
    PubMed     Text format     Abstract available

  56. LIU J, Zhu Y, Qu B
    Reliability and validity of the Chinese version of the Medical Outcomes Study HIV Health Survey (MOS-HIV) in people living with HIV/AIDS (PLWHA) in China.
    PLoS One. 2018;13:e0201177.
    PubMed     Text format     Abstract available

  57. CUYPERS L, Perez AB, Chueca N, Aldamiz-Echevarria T, et al
    Relapse or reinfection after failing hepatitis C direct acting antiviral treatment: Unravelled by phylogenetic analysis.
    PLoS One. 2018;13:e0201268.
    PubMed     Text format     Abstract available

  58. ONGWANDEE S, Lertpiriyasuwat C, Khawcharoenporn T, Chetchotisak P, et al
    Implementation of a Test, Treat, and Prevent HIV program among men who have sex with men and transgender women in Thailand, 2015-2016.
    PLoS One. 2018;13:e0201171.
    PubMed     Text format     Abstract available

  59. FISHER CB, Fried AL, Ibrahim Puri L, Macapagal K, et al
    "Free Testing and PrEP without Outing Myself to Parents:" Motivation to participate in oral and injectable PrEP clinical trials among adolescent men who have sex with men.
    PLoS One. 2018;13:e0200560.
    PubMed     Text format     Abstract available


    PLoS Pathog

  60. DZHIVHUHO GA, Rehrl SA, Ndlovu H, Horsnell WGC, et al
    Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model.
    PLoS Pathog. 2018;14:e1007182.
    PubMed     Text format     Abstract available


    Vaccine

  61. NADARZYNSKI T, Smith H, Richardson D, Bremner S, et al
    Men who have sex with men who do not access sexual health clinics nor disclose sexual orientation are unlikely to receive the HPV vaccine in the UK.
    Vaccine. 2018;36:5065-5070.
    PubMed     Text format     Abstract available

  62. VIRNIK K, Nesti E, Dail C, Scanlan A, et al
    Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost.
    Vaccine. 2018 Jul 20. pii: S0264-410X(18)30940.
    PubMed     Text format     Abstract available


    Virology

  63. JAGUVA VASUDEVAN AA, Bahr A, Grothmann R, Singer A, et al
    MXB inhibits murine cytomegalovirus.
    Virology. 2018;522:158-167.
    PubMed     Text format     Abstract available

  64. LIU H, Hu PW, Couturier J, Lewis DE, et al
    HIV-1 replication in CD4(+) T cells exploits the down-regulation of antiviral NEAT1 long non-coding RNAs following T cell activation.
    Virology. 2018;522:193-198.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: